Company: XAIR
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021561
Chunk: 40

Company: Beyond Air, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 40
---
 provided however, that Streeterville is guaranteed 12 months of interest, of $1.8 million even
if the Note is redeemed or prepaid prior to the maturity date. Of the total $12.0 million Note, $6.0 million will be placed in a restricted account and will be accessible by the Company
as the first $6.0 million is repaid.

Also
on November 4, 2025, the Company entered into an equity purchase agreement (the “Purchase Agreement”) with Streeterville
for the purchase of up to $20.0 million of the Company’s shares of common stock. In connection with the Purchase Agreement,
the Company and Streeterville entered into a registration rights agreement (the “Registration Rights Agreement”),
pursuant to which the Company agreed to file with the Securities and Exchange Commission a registration statement (the
“Registration Statement”) covering the resale of the shares by November 24, 2025. Pursuant to the Purchase Agreement,
upon effectiveness of the Registration Statement and so long as there is no balance outstanding on the Note, the Company shall have
the right, but not the obligation, to direct Streeterville, by its delivery to Streeterville of a put notice from time to time during a period of up to
two years, to purchase newly issued shares of the Company’s common stock, subject to customary limitations.

On
November 3, 2025, the Company amended and restated the original Loan Agreement (as amended, the
“Amended Loan Agreement”) to provide for and finalize the terms of the $2.0 million Additional Loans and the issuance of
new five-year warrants to purchase up to 512,821 shares of the Company’s common stock (the “Supplemental
Warrants”) with an exercise price of $1.95 per share and subject to the same terms and conditions applicable to the existing
warrants issued under the original Loan and Security Agreement (the “2024 Debt Warrants”). Concurrently, the parties
entered into a waiver agreement pursuant to which the Lender consented to the Company’s issuance of the Note in exchange for reducing
the exercise price of the 2024 Debt Warrants  from  $7.59 per
share to $1.95 per share.

On
November 4, 2025, the board of directors approved a one-time stock option repricing of 726,618 options (the “Option
Repricing”), effective November 4, 2025. The Option Re